In melanoma, metformin has been found to inhibit cancer cell invasion, proliferation, and epithelial–mesenchymal transition through the activation of AMPK and the inhibition of MMP2 and MMP9 expression [33]. The gene discussed is PRKAA1; the disease is melanoma.